We've updated our Privacy Policy. Questions? Email us any time at privacy@ground.newsWe've updated our Privacy Policy with additional info on research surveys, our browser extension, cookie management, and ad performance measurement. Questions? Email us any time at privacy@ground.news
The global market for anti-obesity drugs is expected to reach $130 billion by 2030, according to Goldman Sachs, as soaring demand for blockbuster treatments such as Ozempic and Mounjaro reshapes the pharmaceutical industry.